XINT Q2 2026 higher sales, XSTEM clinical progress, stronger financing
XINT reported Q2 2026 higher sales, clinical progress for XSTEM, and strengthened financing.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
XINT reported Q2 2026 higher sales, clinical progress for XSTEM, and strengthened financing.